Jungang Vaccine Decides to Acquire Treasury Shares Worth 1.5 Billion Won
[Asia Economy Reporter Lee Seon-ae] Jungang Vaccine announced on the 8th that it has decided to acquire 100,000 treasury shares on the market to enhance shareholder value through stock price stabilization.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The expected acquisition amount is 1.475 billion KRW, and the expected acquisition period is from the 12th of this month to January 11, 2022.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
